Early autologous stem cell transplantation for poor-risk Chronic Lymphocytic Leukemia (CLL): prognostic factors for feasibility and molecular outcome

被引：0
|
作者：
Dreger, P
von Neuhoff, N
Wittkowsky, G
Sonnen, R
Seyfarth, B
Kuse, R
Glass, B
Schmitz, N
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S36 / S37
页数：2
相关论文
共 50 条
  • [11] Long term outcome of autologous stem cell transplantation for chronic lymphocytic leukemia or small lymphocytic lymphoma (B-CLL).
    Pavletic, Z
    Bierman, P
    Vose, J
    Bishop, M
    Wu, D
    Pierson, J
    Kollath, J
    Kessinger, A
    Armitage, J
    BLOOD, 1997, 90 (10) : 1032 - 1032
  • [12] Outcome following autologous or allogeneic stem cell transplantation in chronic lymphocytic leukemia
    Gribben, JG
    Sequist, L
    Zahrieh, D
    Neuberg, D
    Alyea, EP
    Fisher, DC
    Freedman, AS
    Schlossman, RL
    Soiffer, RJ
    Ritz, J
    Nadler, LM
    BLOOD, 2003, 102 (11) : 980A - 981A
  • [13] Outcome Of Chronic Lymphocytic Leukemia (CLL) Patients That Failed Allogeneic Stem Cell Transplantation
    Benjamini, Ohad
    Rozovski, Uri
    Jain, Preetesh
    Wierda, William G.
    O'Brien, Susan
    Burger, Jan A.
    Ferrajoli, Alessandra
    Faderl, Stefan H.
    Shpall, Elizabeth J.
    Hosing, Chitra M.
    Khouri, Issa F.
    Champlin, Richard E.
    Keating, Michael J.
    Estrov, Zeev
    BLOOD, 2013, 122 (21)
  • [14] Outcome of Chronic Lymphocytic Leukemia (CLL) Patients That Failed Allogeneic Stem Cell Transplantation
    Benjamini, Ohad
    Rozovski, Uri
    Jain, Preetesh
    Wierda, William G.
    O'Brien, Susan
    Burger, Jan
    Ferrajoll, Alessandra
    Faderl, Stefan
    Shpall, Elizabeth
    Hosing, Chitra
    Khouri, Issa F.
    Champlin, Richard
    Keating, Michael J.
    Estrov, Zeev
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S130 - S131
  • [15] Autologous stem cell transplantation for chronic lymphocytic leukemia
    Dreger, Peter
    Brand, Ronald
    Michallet, Mauricette
    SEMINARS IN HEMATOLOGY, 2007, 44 (04) : 246 - 251
  • [16] Current strategies for the diagnosis and management of chronic lymphocytic leukemia (CLL), with a focus on poor-risk CLL: A review
    Mc Clanahan, Fabienne
    Dreger, Peter
    TURKISH JOURNAL OF HEMATOLOGY, 2011, 28 (02) : 86 - 96
  • [17] Practical Aspects of Allogeneic Hematopoietic Cell Transplantation for Patients with Poor-Risk Chronic Lymphocytic Leukemia
    Delgado, Julio
    Duarte, Rafael F.
    THESCIENTIFICWORLDJOURNAL, 2011, 11 : 161 - 172
  • [18] A prospective multicenter trial on nonmyeloablative allogeneic stem cell transplantation (NST) for poor-risk chronic lymphocytic leukemia (CLL):: Final results of the GCLLSG CLL3X study
    Dreger, P.
    Stilgenbauer, S.
    Boettcher, S.
    Ritgen, M.
    Busch, R.
    Bunjes, D.
    Beelen, D.
    Cohen, S.
    Hegenbart, U.
    Schubert, J.
    Hertenstein, B.
    Stadler, M.
    Glass, B.
    Burchert, A.
    Uharek, L.
    Basara, N.
    Humpe, A.
    Duehrsen, U.
    Hallek, M.
    Schmitz, N.
    Kneba, M.
    Doehner, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 102 - 102
  • [19] Quality of life (QoL) assessment in patients allografted for poor-risk chronic lymphocytic leukemia (CLL)
    Hahn, M.
    Dietrich, S.
    Hegenbart, U.
    Bondong, A.
    Ho, A. D.
    Dreger, P.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S422 - S422
  • [20] Role of autologous stem cell transplantation in chronic lymphocytic leukemia
    Rizouli, V
    Gribben, JG
    CURRENT OPINION IN HEMATOLOGY, 2003, 10 (04) : 306 - 311
12345